PlainRecalls
FDA Drug Moderate Class II Terminated

Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)

Reported: November 2, 2022 Initiated: September 30, 2022 #D-0020-2023

Product Description

Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)

Reason for Recall

Subpotent Drug: Out of specification for assay

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
11,520 units
Distribution
Nationwide in the USA
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe). Recalled by AuroMedics Pharma LLC. Units affected: 11,520 units.
Why was this product recalled?
Subpotent Drug: Out of specification for assay
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2022. Severity: Moderate. Recall number: D-0020-2023.